Request Demo
Last update 23 Jan 2025
Wuhan Kangfude Biotechnology Co., Ltd.
Last update 23 Jan 2025
Overview
Tags
Congenital Disorders
Endocrinology and Metabolic Disease
Other Diseases
Recombinant protein
Enzyme
Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
No Data
Related
Target |
Mechanism |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest Phase |
First Approval Ctry. / Loc. |
First Approval Date |
Target |
Mechanism |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest Phase |
First Approval Ctry. / Loc. |
First Approval Date |
Target |
Mechanism |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest Phase |
First Approval Ctry. / Loc. |
First Approval Date |
CTR20230413
评价继发性高草酸尿症患者口服重组草酸脱羧酶散的安全性和有效性的多中心、随机、双盲、安慰剂对照 II 期临床研究
[Translation] A multicenter, randomized, double-blind, placebo-controlled phase II clinical study to evaluate the safety and efficacy of oral recombinant oxalate decarboxylase powder in patients with secondary hyperoxaluria
CTR20221023
单中心、随机、双盲、剂量递增、安慰剂对照设计，评价重组草酸脱羧酶散在中国成年健康受试者中单次给药及多次给药的安全性、耐受性临床试验
[Translation] A single-center, randomized, double-blind, dose-escalation, placebo-controlled clinical trial to evaluate the safety and tolerability of single and multiple doses of recombinant oxalate decarboxylase powder in healthy adult Chinese subjects
100 Clinical Results associated with Wuhan Kangfude Biotechnology Co., Ltd.
Login to view more data
Login to view more data
100 Deals associated with Wuhan Kangfude Biotechnology Co., Ltd.
Login to view more data
100 Translational Medicine associated with Wuhan Kangfude Biotechnology Co., Ltd.
Login to view more data
Corporation Tree
Boost your research with our corporation tree data.
login
or
Pipeline
Pipeline Snapshot as of 18 Feb 2025
The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Preclinical
2
1
Phase 2 Clinical
Other
1
Login to view more data
Current Projects
Login to view more data
Deal
Boost your decision using our deal data.
login
or
Translational Medicine
Boost your research with our translational medicine data.
login
or
Profit
Explore the financial positions of over 360K organizations with Synapse.
login
or
Grant & Funding(NIH)
Access more than 2 million grant and funding information to elevate your research journey.
login
or
Investment
Gain insights on the latest company investments from start-ups to established corporations.
login
or
Financing
Unearth financing trends to validate and advance investment opportunities.
login
or
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free